A recent study showed that inhibiting OGA promotes the differentiation of CD34+ hematopoietic stem and progenitor cells (HSPCs) and acute myeloid leukemia (AML) cells into DC via STAT3/5 signaling (47). Here, STAT3 is linked to acute myeloid leukemia.